Vanessa Gómez‐Rangel

From single drug targets to synergistic network pharmacology in ischemic stroke

Ana I. Casas, Ahmed Hassan, Simon J. Larsen et al. · Proceedings of the National Academy of Sciences · 2019 · 231 citations · Full text

Nrf2 participates in depressive disorders through an anti-inflammatory mechanism

María Dolores Martin‐de‐Saavedra, Josiane Budni, Maurício P. Cunha et al. · Psychoneuroendocrinology · 2013 · 142 citations

Inflammation, Psychoneuroimmunology, Psychiatry +8

Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice

Andiara E. Freitas, Javier Egea, Izaskun Buendía et al. · Molecular Neurobiology · 2015 · 104 citations

Psychoneuroimmunology, Stress Hormone, Behavioral Neuroscience +13

Early toll‐like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro‐inflammatory phenotype in rodent and human brain ischaemia models

Esther Parada, Ana I. Casas, Alejandra Palomino‐Antolín et al. · British Journal of Pharmacology · 2019 · 57 citations · Full text

Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux

Víctor Farré‐Alins, Paloma Narros‐Fernández, Alejandra Palomino‐Antolín et al. · Antioxidants · 2020 · 41 citations · Full text

Immunology, Immune Regulation, Cell Death +19